Articles From: NOVADAQ to Host Analyst & Investor Day on November 17, 2014 to Novo Nordisk A/S : Status regarding Novo Nordisk's holding of its own shares (30 September 2014)


TORONTO, Sept.
Sign-up for NOVADAQ to Host Analyst & Investor Day on November 17, 2014 investment picks
TORONTO, July 22, 2014 (GLOBE NEWSWIRE) -- Novadaq ® Technologies Inc. ("NOVADAQ" or "the Company") (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the second quarter of 2014 before markets open on Tuesday, August 5, 2014.
Sign-up for NOVADAQ to Release Second Quarter Financial Results on August 5, 2014 -- Conference Call to Follow investment picks
2014/7/31
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G019385-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/7/31/11G019385/novagant-754099074534.jpg DENVER, CO--(Marketwired - July 31, 2014) - Novagant Corp.
Sign-up for Novagant Corp. Delivered the First Pallet of AlKanna LED Grow Lights to a Retailer investment picks
2014/8/1
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G019430-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/1/11G019430/novagant-754099074534.jpg DENVER, CO--(Marketwired - August 01, 2014) - Novagant Corp.
Sign-up for Novagant Corp. Makes GoldenCBD(TM) 15-Capsules Bottle Available to Retailers as of August 1, 2014 investment picks
DENVER , July 16, 2014 /PRNewswire/ -- Novagant Corp.
Sign-up for Novagant Introduces GoldenCBD™ Edibles and Ingestable Products Line investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G018248-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/7/15/11G018248/novagant-754099074534.jpg DENVER, CO--(Marketwired - July 15, 2014) - Novagant, Inc. (PINKSHEETS: NVGT). The Company is pleased to update its shareholders and supporters that it is aggressively in the process of expanding its Cannabidiol (CBD) product line as a follow-up to its recent announcements of its GLAVAPE™ (Generally Legal American Vape) medical cannabis vaporizer product based on CBD-rich hemp oil and of its newly launched E-Commerce portal website for its new GLAVAPE™ product at www.glavape.com .
Sign-up for Novagant on Track to Expand Cannabidiol Product Line investment picks
2014/7/28
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G019164-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/7/28/11G019164/novagant-754099074534.jpg DENVER, CO--(Marketwired - July 28, 2014) - Novagant, Inc. (PINKSHEETS: NVGT) is pleased to announce that it will present its AlKanna LED grow lights, its GLAVape™ medical cannabis vaporizer product, and its GoldenCBD™ Cannabidiol products at the 2014 Money Show in San Francisco, and will be a speaker on the Cannabis Panel at the Money Show.
Sign-up for Novagant, Inc. Will Exhibit Its Cannabidiol Product Lines at the 2014 Money Show and Speak on the Cannabis Panel at the Money Show investment picks
2014/10/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0971692001&sourceType=1 http://media3.marketwire.com/logos/20120904-NG-lg.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for NOVAGOLD Advances Donlin Gold Permitting Past the Halfway Mark, Strengthens Partnerships and Forges Alliance with the National Fish and Wildlife Foundation investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Here are some of the stocks that made notable moves in European trade Monday.
Sign-up for Novartis up, Iliad drops: European movers investment picks
2014/8/30
- Study showed significantly more HF-REF patients on LCZ696 regimen were alive, had fewer hospitalizations than those given enalapril regimen(1) - On all-cause mortality, LCZ696 doubled the effect that enalapril, an ACE-inhibitor, previously showed vs.
Sign-up for Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial investment picks
Novatel Wireless, Inc. (NASDAQ: NVTL, the “Company”), a leading provider of Internet of Things, today announced that it has completed a transaction with HC2 Holdings 2, Inc. (“HC2”), a wholly owned subsidiary of HC2 Holdings, Inc. (HCHC), for a strategic investment in the Company.
Sign-up for Novatel Wireless Announces Strategic Investment from HC2 investment picks
SAN DIEGO, Oct.
Sign-up for Novatel Wireless Announces Ticker Symbol Change to MIFI investment picks
Novatel Wireless, Inc. (NASDAQ: NVTL), a leading provider of Internet of Things, announced that the Company has appointed Michael Newman as Executive Vice President and Chief Financial Officer.
Sign-up for Novatel Wireless Appoints Chief Financial Officer investment picks
Novatel Wireless, Inc. (NASDAQ: NVTL), a leading provider of Internet of Things (IoT) wireless solutions, announced financial results for the second quarter ended June 30, 2014.
Sign-up for Novatel Wireless Reports Second Quarter 2014 Financial Results investment picks
Novatel Wireless, Inc. (Nasdaq:NVTL), a leading provider of Internet of Things, today announced that management will present at the Rodman & Renshaw 16 th Annual Global Investment Conference.
Sign-up for Novatel Wireless to Present at Rodman & Renshaw 16th Annual Global Investment Conference investment picks
Novatel Wireless (NASDAQ:NVTL), a leading provider of intelligent wireless solutions, will release financial results for the quarter ended June 30, 2014 after the stock market close on Wednesday, August 6, 2014.
Sign-up for Novatel Wireless to Report Second Quarter 2014 Financial Results on August 6, 2014 investment picks
2014/9/3
IRVINE, Calif.
Sign-up for Novation Enters Into First Sole-Source Heart Valve Agreement With Edwards Lifesciences investment picks
Award of Option Period for 24 months Additional Option Period Funding Commitment of $70 million Clinical, Manufacturing and Product Development Activities Funded Up to Phase 3 GAITHERSBURG, Md., Sept.
Sign-up for Novavax Announces BARDA Exercise of Contract Option investment picks
GAITHERSBURG, Md., Sept.
Sign-up for Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC investment picks
GAITHERSBURG, Md., Aug.
Sign-up for Novavax Reports Second-Quarter 2014 Financial Results investment picks
GAITHERSBURG, Md., Sept.
Sign-up for Novavax to Host 2nd Annual Analyst and Investor Meeting investment picks
ROCKVILLE, Md., July 30, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced today that it will report its financial results for the second quarter of 2014 on Wednesday, August 6, 2014, after market close.
Sign-up for Novavax to Host Conference Call to Discuss Second Quarter 2014 Financial Results on August 6, 2014 investment picks
GAITHERSBURG, Md., Aug.
Sign-up for Novavax to Present at the Wedbush Securities Life Sciences Management Access Conference investment picks
GAITHERSBURG, Md., Sept.
Sign-up for Novavax to Present RSV Vaccine Clinical and Preclinical Results at ICAAC investment picks
Vaccine and adjuvant were well-tolerated, consistent with the company's prior studies with saponin-based adjuvants Hemagglutination-inhibiting antibody responses similar to prior Novavax studies of A(H7N9) with another saponin adjuvant Strong neuraminidase inhibiting antibody responses in adjuvanted vaccine groups Matrix-M demonstrated a clear dose response GAITHERSBURG, Md., Sept.
Sign-up for Novavax' H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM) Delivers Positive Phase 1/2 Clinical Data investment picks
2014/8/27
Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomes MADISON, N.J. , Aug.
Sign-up for Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study investment picks
2014/9/26
LISBON--Portugal's Novo Banco, which kept the good assets of collapsed Banco Esprito Santo SA, will propose that retail clients holding certain bonds of its former bank convert their investments into deposits so they can recover them in full, according to people familiar with the offer.
Sign-up for Novo Banco to Offer Plan for Banco Espirito Bondholders investment picks
BAGSVAERD, Denmark, Oct.
Sign-up for Novo Nordisk A/S : Status regarding Novo Nordisk's holding of its own shares (30 September 2014) investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: NOVADAQ to Host Analyst & Investor Day on November 17, 2014 to Novo Nordisk A/S : Status regarding Novo Nordisk's holding of its own shares (30 September 2014)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices